Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akshaya Murugesan

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Apoptosis : an International Journal on Programmed Cell Death|June 17, 2022
Programmed cell death detection methods: a systematic review and a categorical comparisonSana Kari, Kumar Subramanian, Ilenia Agata Altomonte, et al.
Future Medicinal Chemistry|September 10, 2021
Functional characterization of HIC, a P2Y1 agonist, as a p53 stabilizer for prostate cancer cell death inductionHien Thi Thu Le, Akshaya Murugesan, Nuno R Candeias, et al.
Cells|August 27, 2021
Alkylaminophenol and GPR17 Agonist for Glioblastoma Therapy: A Combinational Approach for Enhanced Cell Death ActivityPhuong Doan, Phung Nguyen, Akshaya Murugesan, et al.
Journal of Biomolecular Structure & Dynamics|September 20, 2021
Molecular modeling and dynamics studies of the synthetic small molecule agonists with GPR17 and P2Y1 receptorAkshaya Murugesan, Phung Nguyen, Thiyagarajan Ramesh, et al.
Journal of Ethnopharmacology|June 9, 2025
Anti-GBM effects of polyphenolic extract from Avicennia marinaAkshaya Murugesan, Phuong Doan, Priyatharsini Rajendran, et al.
European Journal of Pharmacology|July 27, 2025
Graphitic carbon nitride nanoparticle: g-C<sub>3</sub>N<sub>4</sub> synthesis, characterization, and its biological activity against glioblastomaAnxo Vila Alonso, Akshaya Murugesan, Rituporn Gogoi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 30, 2023
Bias-force guided simulations combined with experimental validations towards GPR17 modulators identificationSana Kari, Akshaya Murugesan, Ramesh Thiyagarajan, et al.
Apoptosis : an International Journal on Programmed Cell Death|February 7, 2022
P2Y1 agonist HIC in combination with androgen receptor inhibitor abiraterone acetate impairs cell growth of prostate cancerHien Thi Thu Le, Akshaya Murugesan, Nuno R Candeias, et al.
International Journal of Biological Macromolecules|August 23, 2021
Molecular interaction of HIC, an agonist of P2Y1 receptor, and its role in prostate cancer apoptosisHien Thi Thu Le, Akshaya Murugesan, Thiyagarajan Ramesh, et al.
International Journal of Molecular Sciences|August 12, 2023
Benzenesulfonamide Analogs: Synthesis, Anti-GBM Activity and PharmacoprofilingAkshaya Murugesan, Saravanan Konda Mani, Ramesh Thiyagarajan, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Apoptosis : an International Journal on Programmed Cell Death|June 17, 2022
Programmed cell death detection methods: a systematic review and a categorical comparisonSana Kari, Kumar Subramanian, Ilenia Agata Altomonte, et al.
Future Medicinal Chemistry|September 10, 2021
Functional characterization of HIC, a P2Y1 agonist, as a p53 stabilizer for prostate cancer cell death inductionHien Thi Thu Le, Akshaya Murugesan, Nuno R Candeias, et al.
Cells|August 27, 2021
Alkylaminophenol and GPR17 Agonist for Glioblastoma Therapy: A Combinational Approach for Enhanced Cell Death ActivityPhuong Doan, Phung Nguyen, Akshaya Murugesan, et al.
Journal of Biomolecular Structure & Dynamics|September 20, 2021
Molecular modeling and dynamics studies of the synthetic small molecule agonists with GPR17 and P2Y1 receptorAkshaya Murugesan, Phung Nguyen, Thiyagarajan Ramesh, et al.
Journal of Ethnopharmacology|June 9, 2025
Anti-GBM effects of polyphenolic extract from Avicennia marinaAkshaya Murugesan, Phuong Doan, Priyatharsini Rajendran, et al.
European Journal of Pharmacology|July 27, 2025
Graphitic carbon nitride nanoparticle: g-C<sub>3</sub>N<sub>4</sub> synthesis, characterization, and its biological activity against glioblastomaAnxo Vila Alonso, Akshaya Murugesan, Rituporn Gogoi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 30, 2023
Bias-force guided simulations combined with experimental validations towards GPR17 modulators identificationSana Kari, Akshaya Murugesan, Ramesh Thiyagarajan, et al.
Apoptosis : an International Journal on Programmed Cell Death|February 7, 2022
P2Y1 agonist HIC in combination with androgen receptor inhibitor abiraterone acetate impairs cell growth of prostate cancerHien Thi Thu Le, Akshaya Murugesan, Nuno R Candeias, et al.
International Journal of Biological Macromolecules|August 23, 2021
Molecular interaction of HIC, an agonist of P2Y1 receptor, and its role in prostate cancer apoptosisHien Thi Thu Le, Akshaya Murugesan, Thiyagarajan Ramesh, et al.
International Journal of Molecular Sciences|August 12, 2023
Benzenesulfonamide Analogs: Synthesis, Anti-GBM Activity and PharmacoprofilingAkshaya Murugesan, Saravanan Konda Mani, Ramesh Thiyagarajan, et al.
Pageof 4